Collegium Pharmaceutical, Inc. (COLL)

Collegium Pharmaceutical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	631.45	566.77	463.93	276.87	310.02
Revenue Growth (YoY)	11.41%	22.17%	67.56%	-10.69%	4.49%
Cost of Revenue	83.53	79.72	118.19	59.07	69.5
Gross Profit	547.92	487.05	345.74	217.8	240.52
Selling, General & Admin	182.98	150.71	172.19	118.96	113.83
Research & Development	-	-	3.98	9.45	9.77
Operating Expenses	348.29	296.47	307.64	195.59	184.28
Operating Income	199.63	190.58	38.11	22.21	56.23
Interest Expense	-73.97	-83.34	-63.21	-21.01	-28.88
Interest & Investment Income	13.98	15.62	1.05	0.01	0.23
EBT Excluding Unusual Items	139.63	122.85	-24.06	1.2	27.58
Merger & Restructuring Charges	-29.6	-15.12	-	-4.58	-
Asset Writedown	-	-	-4.79	-	-
Legal Settlements	-	-8.5	-	-	-
Other Unusual Items	-11.47	-23.5	-	-	-
Pretax Income	98.57	75.73	-28.85	-3.37	27.58
Income Tax Expense	29.38	27.58	-3.85	-74.89	0.83
Net Income	69.19	48.16	-25	71.52	26.75
Net Income to Common	69.19	48.16	-25	71.52	26.75
Net Income Growth	43.68%	-	-	167.33%	-
Shares Outstanding (Basic)	32	34	34	35	34
Shares Outstanding (Diluted)	40	42	34	41	35
Shares Change (YoY)	-3.26%	23.53%	-17.58%	16.77%	5.07%
EPS (Basic)	2.14	1.43	-0.74	2.05	0.78
EPS (Diluted)	1.86	1.29	-0.74	1.86	0.76
EPS Growth	43.56%	-	-	144.25%	-
Free Cash Flow	203.33	274.29	122.61	101.61	88.4
Free Cash Flow Per Share	5.03	6.56	3.62	2.48	2.52
Gross Margin	86.77%	85.93%	74.52%	78.66%	77.58%
Operating Margin	31.61%	33.63%	8.21%	8.02%	18.14%
Profit Margin	10.96%	8.50%	-5.39%	25.83%	8.63%
Free Cash Flow Margin	32.20%	48.39%	26.43%	36.70%	28.51%
EBITDA	368.79	339.83	172.26	91.12	117.78
EBITDA Margin	58.40%	59.96%	37.13%	32.91%	37.99%
D&A For EBITDA	169.16	149.26	134.15	68.92	61.55
EBIT	199.63	190.58	38.11	22.21	56.23
EBIT Margin	31.61%	33.63%	8.21%	8.02%	18.14%
Effective Tax Rate	29.80%	36.41%	-	-	3.01%
Advertising Expenses	10.66	7.41	11.74	4.19	5.37

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q